These outcomes, together with a earlier report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two support the concept of targeting ACKR3 as a singular way to modulate the opioid procedure, which could open new therapeutic avenues for opioid-related